Literature DB >> 19657750

The finding of a reciprocal whole-arm translocation t(X;12)(p10;p10) in association with atypical chronic myeloid leukaemia.

P T Elder1, M F McMullin, M W Humphreys, J Hamilton, P McGrattan.   

Abstract

Atypical chronic myeloid leukaemia (aCML) belongs to the myeloproliferative/myelodysplastic category of haematological disease. Main characteristics are marked dysgranulopoiesis, bone marrow dysfunction and the failure to demonstrate the presence of the Philadelphia chromosome or BCR/ABL fusion gene normally associated with CML t(9;22)(q34;q11). It carries a poor prognosis with limited therapeutic options available. Most cases of aCML have one or more karyotypic abnormalities. We highlight a clinical presentation of aCML associated with an acquired reciprocal whole-arm translocation (WAT), t(X;12)(p10;p10), which to our knowledge has not yet been described. We also discuss how such a translocation might lead to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657750     DOI: 10.1007/s12032-009-9282-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  8 in total

Review 1.  Centric and pericentric chromosome rearrangements in hematopoietic malignancies.

Authors:  R Berger; M Busson-Le Coniat
Journal:  Leukemia       Date:  1999-05       Impact factor: 11.528

2.  Cytogenetically balanced translocations are associated with focal copy number alterations.

Authors:  Spencer K Watson; Ronald J deLeeuw; Doug E Horsman; Jeremy A Squire; Wan L Lam
Journal:  Hum Genet       Date:  2006-10-19       Impact factor: 4.132

3.  Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.

Authors:  J M Hernández; M C del Cañizo; A Cuneo; J L García; N C Gutiérrez; M González; G Castoldi; J F San Miguel
Journal:  Ann Oncol       Date:  2000-04       Impact factor: 32.976

Review 4.  Oncogenic transcription factors in the human acute leukemias.

Authors:  A T Look
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

5.  BCR rearrangement-negative chronic myelogenous leukemia revisited.

Authors:  R Kurzrock; C E Bueso-Ramos; H Kantarjian; E Freireich; S L Tucker; M Siciliano; S Pilat; M Talpaz
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

6.  Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Authors:  Brian J Druker; François Guilhot; Stephen G O'Brien; Insa Gathmann; Hagop Kantarjian; Norbert Gattermann; Michael W N Deininger; Richard T Silver; John M Goldman; Richard M Stone; Francisco Cervantes; Andreas Hochhaus; Bayard L Powell; Janice L Gabrilove; Philippe Rousselot; Josy Reiffers; Jan J Cornelissen; Timothy Hughes; Hermine Agis; Thomas Fischer; Gregor Verhoef; John Shepherd; Giuseppe Saglio; Alois Gratwohl; Johan L Nielsen; Jerald P Radich; Bengt Simonsson; Kerry Taylor; Michele Baccarani; Charlene So; Laurie Letvak; Richard A Larson
Journal:  N Engl J Med       Date:  2006-12-07       Impact factor: 91.245

7.  Integration of conventional cytogenetics, comparative genomic hybridisation and interphase fluorescence in situ hybridisation for the detection of genomic rearrangements in acute leukaemia.

Authors:  P McGrattan; S Campbell; R Cuthbert; F G C Jones; M F McMullin; M Humphreys
Journal:  J Clin Pathol       Date:  2008-05-12       Impact factor: 3.411

8.  Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.

Authors:  Francesco Onida; Greg Ball; Hagop M Kantarjian; Terry L Smith; Armand Glassman; Maher Albitar; Barbara Scappini; Mary Beth Rios; Michael J Keating; Miloslav Beran
Journal:  Cancer       Date:  2002-10-15       Impact factor: 6.860

  8 in total
  1 in total

1.  Genomic instability in chronic myeloid leukemia: targets for therapy?

Authors:  N Muvarak; P Nagaria; F V Rassool
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.